SMC approval welcome news for breast cancer patients
Trodelvy is accepted for use in mTNBC patients who have already received two or more systemic therapies
Read More
Author: John Pinching
Gene team supports therapies for previously untreatable brain regions
Novartis and Voyager Therapeutics announce partnership to develop gene therapies for neurological disorders
Read More
Cell door: EMA grants ATMP classification to CELTIC-19
Advanced Therapy Medicinal Product classification for Ixaka Ltd’s chemically encapsulated lentiviral vector
Read More
Roche launches molecular system to increase diagnostic testing access
Fully-automated molecular system with small footprint provides greater flexibility for laboratories without much space
Read More
First treatment for adults across full spectrum of chronic heart failure
Largest unmet need in cardiovascular medicine finally receives approved therapy
Read More- Kahimmune Therapeutics enters licensing agreement with Gustave Roussy and SATT Paris-Saclay
- IBSA UK&I launches Perovial for the treatment of acute Peyronie’s disease
- En Carta Diagnostics’ EC Pocket Lyme test receives FDA Breakthrough Device Designation
- ALK’s EURneffy receives positive CHMP opinion for emergency anaphylaxis treatment in children
- CERo reports encouraging early data from phase 1 trial of CER‑1236
